Tidemark’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$268K Buy
1,056
+3
+0.3% +$699 0.06% 130
2026
Q1
$258K Sell
1,053
-930
-47% -$217K 0.07% 125
2025
Q4
$410K Buy
1,983
+2
+0.1% +$395 0.12% 85
2025
Q3
$367K Buy
1,981
+474
+31% +$81.2K 0.11% 89
2025
Q2
$230K Buy
1,507
+3
+0.2% +$461 0.07% 109
2025
Q1
$249K Buy
1,504
+2
+0.1% +$313 0.09% 101
2024
Q4
$217K Sell
1,502
-23
-2% -$3.56K 0.08% 104
2024
Q3
$247K Buy
1,525
+3
+0.2% +$478 0.1% 97
2024
Q2
$223K Sell
1,522
-179
-11% -$26.6K 0.1% 99
2024
Q1
$269K Sell
1,701
-457
-21% -$72.7K 0.15% 100
2023
Q4
$338K Buy
+2,158
New +$331K 0.21% 76

Other funds holding JNJ

Tidemark's JNJ Position: Q2 2026 in Review

Tidemark increased its Johnson & Johnson (JNJ) stake by 0.28% in Q2 2026, buying an estimated $699 and bringing the position to 1,056 shares worth $268K. The position accounts for 0.06% of the portfolio, ranked #130.

Tidemark first reported a position in JNJ in Q4 2023 and has held it in 11 quarters since. The position peaked at $410K in Q4 2025. 4,655 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Tidemark held 1,056 shares of Johnson & Johnson worth $268K as of Q2 2026.
  • Tidemark bought 3 Johnson & Johnson shares in Q2 2026, an estimated $699.
  • Johnson & Johnson made up 0.06% of Tidemark's portfolio in Q2 2026, its #130 holding.
  • Tidemark first reported a position in Johnson & Johnson in Q4 2023 and has held it in 11 quarters since.
  • Tidemark's Johnson & Johnson position peaked at $410K in Q4 2025.
  • 4,655 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Tidemark's 13F filing for Q2 2026, filed 10 Aug 2026.